Company / Return on Assets (ROA)
Valion Bio, Inc. Return on Assets (ROA) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-293.7%
FY2024
5-year range
-293.7% / -145.0%
FY2022-FY2024
Trend
-50.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -145.0% to -293.7% over the past 2 years.
Based on SEC 10-K filings.
-293.7% in FY2024.
Declined from -145.0% to -293.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 50.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -293.7% | -50.0% |
| FY2023 | -195.8% | -35.0% |
| FY2022 | -145.0% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026